Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 125

    1.

    Personalized medicine: Factors influencing reimbursement.

    Meckley LM, Neumann PJ.

    Health Policy. 2009 Oct 6. [Epub ahead of print]PMID: 19815307 [PubMed - as supplied by publisher]Related articles

    2.

    30 years of pharmaceutical cost-utility analyses: growth, diversity and methodological improvement.

    Neumann PJ, Fang CH, Cohen JT.

    Pharmacoeconomics. 2009;27(10):861-72. doi: 10.2165/11312720-000000000-00000.PMID: 19803540 [PubMed - in process]Related articles

    3.

    The Adoption of Cost-Effectiveness Acceptability Curves in Cost-Utility Analyses.

    Meckley LM, Greenberg D, Cohen JT, Neumann PJ.

    Med Decis Making. 2009 Sep 22. [Epub ahead of print]PMID: 19773582 [PubMed - as supplied by publisher]Related articles

    4.

    Patient adherence: a blind spot in cost-effectiveness analyses?

    Rosen AB, Spaulding AB, Greenberg D, Palmer JA, Neumann PJ.

    Am J Manag Care. 2009 Sep;15(9):626-32.PMID: 19747027 [PubMed - in process]Related articlesFree article

    5.

    Understanding the Medical and Nonmedical Value of Diagnostic Testing.

    Lee DW, Neumann PJ, Rizzo JA.

    Value Health. 2009 Sep 10. [Epub ahead of print]PMID: 19744295 [PubMed - as supplied by publisher]Related articles

    6.

    Is the United States ready for QALYs?

    Neumann PJ, Greenberg D.

    Health Aff (Millwood). 2009 Sep-Oct;28(5):1366-71.PMID: 19738253 [PubMed - in process]Related articles

    7.

    A framework to measure the value of public health services.

    Jacobson PD, Neumann PJ.

    Health Serv Res. 2009 Oct;44(5 Pt 2):1880-96. Epub 2009 Aug 14.PMID: 19686250 [PubMed - indexed for MEDLINE]Related articles

    8.

    Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement.

    Arrighi HM, Neumann PJ, Lieberburg IM, Townsend RJ.

    Alzheimer Dis Assoc Disord. 2009 Jun 29. [Epub ahead of print]PMID: 19568155 [PubMed - as supplied by publisher]Related articles

    9.

    Costing and perspective in published cost-effectiveness analysis.

    Neumann PJ.

    Med Care. 2009 Jul;47(7 Suppl 1):S28-32.PMID: 19536023 [PubMed - indexed for MEDLINE]Related articles

    10.

    Lessons for health technology assessment: it is not only about the evidence.

    Neumann PJ.

    Value Health. 2009 Jun;12 Suppl 2:S45-8. No abstract available. PMID: 19523184 [PubMed - indexed for MEDLINE]Related articles

    11.

    A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial.

    Reindollar RH, Regan MM, Neumann PJ, Levine BS, Thornton KL, Alper MM, Goldman MB.

    Fertil Steril. 2009 Jun 16. [Epub ahead of print]PMID: 19531445 [PubMed - as supplied by publisher]Related articles

    12.

    Standardizing quality assessment of observational studies for decision making in health care.

    Brixner DI, Holtorf AP, Neumann PJ, Malone DC, Watkins JB.

    J Manag Care Pharm. 2009 Apr;15(3):275-83. No abstract available. PMID: 19326959 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Twenty years of cost-effectiveness analysis in medical imaging: are we improving?

    Otero HJ, Rybicki FJ, Greenberg D, Neumann PJ.

    Radiology. 2008 Dec;249(3):917-25.PMID: 19011188 [PubMed - indexed for MEDLINE]Related articles

    14.

    Medicare's national coverage decisions for technologies, 1999-2007.

    Neumann PJ, Kamae MS, Palmer JA.

    Health Aff (Millwood). 2008 Nov-Dec;27(6):1620-31.PMID: 18997221 [PubMed - indexed for MEDLINE]Related articles

    15.

    Drug company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999.

    Palmer JA, Timm AR, Neumann PJ.

    J Manag Care Pharm. 2008 Oct;14(8):749-55.PMID: 18983204 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Measuring the value of public health systems: the disconnect between health economists and public health practitioners.

    Neumann PJ, Jacobson PD, Palmer JA.

    Am J Public Health. 2008 Dec;98(12):2173-80. Epub 2008 Oct 15.PMID: 18923123 [PubMed - indexed for MEDLINE]Related articles

    17.

    Using decision analysis to better evaluate pediatric clinical guidelines.

    Cohen JT, Neumann PJ.

    Health Aff (Millwood). 2008 Sep-Oct;27(5):1467-75.PMID: 18780939 [PubMed - in process]Related articles

    18.

    Reducing cardiovascular disease: opportunities and consequences.

    Neumann PJ, Cohen JT.

    Diabetes Care. 2008 Aug;31(8):1708-9. No abstract available. PMID: 18663235 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    What Ever Happened to FDAMA Section 114? A Look back after 10 Years.

    Neumann PJ.

    Value Health. 2008 Jul 24. [Epub ahead of print] No abstract available. PMID: 18657100 [PubMed - as supplied by publisher]Related articles

    20.

    Decision analytic models for Alzheimer's disease: state of the art and future directions.

    Cohen JT, Neumann PJ.

    Alzheimers Dement. 2008 May;4(3):212-22. Review.PMID: 18631970 [PubMed - indexed for MEDLINE]Related articles

    21.

    Key principles for the improved conduct of health technology assessments for resource allocation decisions.

    Drummond MF, Schwartz JS, Jönsson B, Luce BR, Neumann PJ, Siebert U, Sullivan SD.

    Int J Technol Assess Health Care. 2008 Summer;24(3):244-58; discussion 362-8.PMID: 18601792 [PubMed - indexed for MEDLINE]Related articles

    22.

    A strategic plan for integrating cost-effectiveness analysis into the US healthcare system.

    Neumann PJ, Palmer JA, Daniels N, Quigley K, Gold MR, Chao S; Panel on Integrating Cost-Effectiveness Considerations into Health Policy Decisions.

    Am J Manag Care. 2008 Apr;14(4):185-8.PMID: 18402510 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Migraine frequency and health utilities: findings from a multisite survey.

    Brown JS, Neumann PJ, Papadopoulos G, Ruoff G, Diamond M, Menzin J.

    Value Health. 2008 Mar-Apr;11(2):315-21.PMID: 18380644 [PubMed - indexed for MEDLINE]Related articles

    24.

    Does preventive care save money? Health economics and the presidential candidates.

    Cohen JT, Neumann PJ, Weinstein MC.

    N Engl J Med. 2008 Feb 14;358(7):661-3. No abstract available. PMID: 18272889 [PubMed - indexed for MEDLINE]Related articles

    25.

    Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.

    Garrison LP Jr, Neumann PJ, Erickson P, Marshall D, Mullins CD.

    Value Health. 2007 Sep-Oct;10(5):326-35.PMID: 17888097 [PubMed - indexed for MEDLINE]Related articles

    26.

    Budget impact analyses get some respect.

    Neumann PJ.

    Value Health. 2007 Sep-Oct;10(5):324-5. No abstract available. PMID: 17888096 [PubMed - indexed for MEDLINE]Related articles

    27.

    Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US.

    Ladapo JA, Neumann PJ, Keren R, Prosser LA.

    Pharmacoeconomics. 2007;25(10):817-28. Review.PMID: 17887804 [PubMed - indexed for MEDLINE]Related articles

    28.

    Dialysis facility ownership and epoetin dosing in hemodialysis patients: a medical economic perspective.

    Cohen JT, Neumann PJ.

    Am J Kidney Dis. 2007 Sep;50(3):362-5. No abstract available. PMID: 17720514 [PubMed - indexed for MEDLINE]Related articles

    29.

    Quality of clinical and economic evidence in dossier formulary submissions.

    Colmenero F, Sullivan SD, Palmer JA, Brauer CA, Bungay K, Watkins J, Neumann PJ.

    Am J Manag Care. 2007 Jul;13(7):401-7.PMID: 17620035 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The effect of immediate reading of screening mammograms on medical care utilization and costs after false-positive mammograms.

    Stewart KA, Neumann PJ, Fletcher SW, Barton MB.

    Health Serv Res. 2007 Aug;42(4):1464-82.PMID: 17610433 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits).

    Cohen JT, Neumann PJ.

    Health Aff (Millwood). 2007 May-Jun;26(3):636-46.PMID: 17485738 [PubMed - indexed for MEDLINE]Related articles

    32.

    Challenges ahead for federal technology assessment.

    Neumann PJ.

    Health Aff (Millwood). 2007 Mar-Apr;26(2):w150-2. Epub 2007 Jan 26. Review.PMID: 17259197 [PubMed - indexed for MEDLINE]Related articles

    33.

    Trends in cost effectiveness analyses in orthopaedic surgery.

    Brauer CA, Neumann PJ, Rosen AB.

    Clin Orthop Relat Res. 2007 Apr;457:42-8. Review.PMID: 17242614 [PubMed - indexed for MEDLINE]Related articles

    34.

    Cost-effectiveness of migraine prevention: the case of topiramate in the UK.

    Brown JS, Papadopoulos G, Neumann PJ, Price M, Friedman M, Menzin J.

    Cephalalgia. 2006 Dec;26(12):1473-82.PMID: 17116098 [PubMed - indexed for MEDLINE]Related articles

    35.

    Economic evaluation in the US: what is the missing link?

    Neumann PJ, Sullivan SD.

    Pharmacoeconomics. 2006;24(11):1163-8. Review.PMID: 17067200 [PubMed - indexed for MEDLINE]Related articles

    36.

    Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage.

    Russell MW, Joshi AV, Neumann PJ, Boulanger L, Menzin J.

    Neurology. 2006 Oct 10;67(7):1279-81. Erratum in: Neurology. 2007 Nov 6;69(19):1889-90. PMID: 17030767 [PubMed - indexed for MEDLINE]Related articles

    37.

    Biotechnology and Medicare's new technology policy: lessons from three case studies.

    Keenan PS, Neumann PJ, Phillips KA.

    Health Aff (Millwood). 2006 Sep-Oct;25(5):1260-9.PMID: 16966721 [PubMed - indexed for MEDLINE]Related articles

    38.

    When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature.

    Talmor D, Shapiro N, Greenberg D, Stone PW, Neumann PJ.

    Crit Care Med. 2006 Nov;34(11):2738-47. Review.PMID: 16957636 [PubMed - indexed for MEDLINE]Related articles

    39.

    Trends in the measurement of health utilities in published cost-utility analyses.

    Brauer CA, Rosen AB, Greenberg D, Neumann PJ.

    Value Health. 2006 Jul-Aug;9(4):213-8.PMID: 16903990 [PubMed - indexed for MEDLINE]Related articles

    40.

    The economic burden of intracerebral hemorrhage: evidence from managed care.

    Russell MW, Boulanger L, Joshi AV, Neumann PJ, Menzin J.

    Manag Care Interface. 2006 Jun;19(6):24-8, 34.PMID: 16892657 [PubMed - indexed for MEDLINE]Related articles

    41.

    What affects the quality of economic analysis for life-saving investments?

    Hahn RW, Kosec K, Neumann PJ, Wallsten S.

    Risk Anal. 2006 Jun;26(3):641-55.PMID: 16834624 [PubMed - indexed for MEDLINE]Related articles

    42.

    Emerging lessons from the drug effectiveness review project.

    Neumann PJ.

    Health Aff (Millwood). 2006 Jul-Aug;25(4):W262-71. Epub 2006 Jun 6.PMID: 16757486 [PubMed - indexed for MEDLINE]Related articles

    43.

    Bias in published cost effectiveness studies: systematic review.

    Bell CM, Urbach DR, Ray JG, Bayoumi A, Rosen AB, Greenberg D, Neumann PJ.

    BMJ. 2006 Mar 25;332(7543):699-703. Epub 2006 Feb 22. Review.PMID: 16495332 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Do oncologists believe new cancer drugs offer good value?

    Nadler E, Eckert B, Neumann PJ.

    Oncologist. 2006 Feb;11(2):90-5.PMID: 16476830 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Do drug formulary policies reflect evidence of value?

    Neumann PJ, Lin PJ, Greenberg D, Berger M, Teutsch S, Mansley E, Weinstein MC, Rosen AB.

    Am J Manag Care. 2006 Jan;12(1):30-6.PMID: 16402886 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Quality-adjusted life years: how useful in medico economic studies.

    Brauer CA, Neumann PJ.

    Fundam Clin Pharmacol. 2005 Dec;19(6):603-7. Review.PMID: 16313271 [PubMed - indexed for MEDLINE]Related articles

    47.

    Medicare and cost-effectiveness analysis.

    Neumann PJ, Rosen AB, Weinstein MC.

    N Engl J Med. 2005 Oct 6;353(14):1516-22. No abstract available. PMID: 16207857 [PubMed - indexed for MEDLINE]Related articles

    48.

    Diffusion of published cost-utility analyses in the field of health policy and practice.

    Sonnad SS, Greenberg D, Rosen AB, Neumann PJ.

    Int J Technol Assess Health Care. 2005 Summer;21(3):399-402.PMID: 16110721 [PubMed - indexed for MEDLINE]Related articles

    49.

    Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.

    Brown JS, Papadopoulos G, Neumann PJ, Friedman M, Miller JD, Menzin J.

    Headache. 2005 Sep;45(8):1012-22.PMID: 16109115 [PubMed - indexed for MEDLINE]Related articles

    50.

    Can we better prioritize resources for cost-utility research?

    Neumann PJ, Rosen AB, Greenberg D, Olchanski NV, Pande R, Chapman RH, Stone PW, Ondategui-Parra S, Nadai J, Siegel JE, Weinstein MC.

    Med Decis Making. 2005 Jul-Aug;25(4):429-36.PMID: 16061895 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...